Dr. Lal PathLabs Limited

NSE LALPATHLAB.NS

Dr. Lal PathLabs Limited Price to Book Ratio (P/B) on January 14, 2025: 11.87

Dr. Lal PathLabs Limited Price to Book Ratio (P/B) is 11.87 on January 14, 2025, a -0.50% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.

Dr. Lal PathLabs Limited 52-week high Price to Book Ratio (P/B) is 16.14 on October 09, 2024, which is 35.96% above the current Price to Book Ratio (P/B).
Dr. Lal PathLabs Limited 52-week low Price to Book Ratio (P/B) is 9.94 on March 19, 2024, which is -16.29% below the current Price to Book Ratio (P/B).
Dr. Lal PathLabs Limited average Price to Book Ratio (P/B) for the last 52 weeks is 12.85.

Key data

Date	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield	Price to Earnings Ratio (P/E)

NSE: LALPATHLAB.NS

Dr. Lal PathLabs Limited

CEO	Mr. Shankha Banerjee
IPO Date	Dec. 23, 2015
Location	India
Headquarters	Tower B, SAS Tower
Employees	4,099
Sector	Health Care
Industries Biotechnology Hospitals & Clinics Medical Instruments Pharmaceuticals

Description

Dr. Lal PathLabs Limited provides diagnostic and related healthcare tests and services in India and internationally. It operates laboratories for carrying the pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The company also offers lab staff training; technical; and lab management services. As of March 31, 2022, the company had 277 clinical laboratories, including National Reference Lab at Delhi and Regional Reference Lab at Kolkata; and 4,731 patient service centers and 10,599 pick-up points. Dr. Lal PathLabs Limited was founded in 1949 and is based in Gurugram, India.

Key trends

Past 5 years